Company filings profile · CIK 0001356576
SUPERNUS PHARMACEUTICALS, INC. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for SUPERNUS PHARMACEUTICALS, INC. (SUPN): 12 filings in the last 90 days vs 55 in the prior 90 (filing-velocity cooling ↓ · 0.22×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Jun 21, 2026. Source-linked, daily-refreshed.
Material 8-K events — SUPERNUS PHARMACEUTICALS, INC.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Jun 18, 2026 | Item 5.07; Financial Statements and Exhibits | ↗ |
| May 20, 2026 | Material Direct Financial Obligation; Financial Statements and Exhibits | ↗ |
| May 5, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Apr 22, 2026 | Results of Operations (earnings) | ↗ |
| Apr 7, 2026 | Entry into a Material Agreement; Completion of Acquisition/Disposition; Financial Statements and Exhibits | ↗ |
Watch SUPERNUS PHARMACEUTICALS, INC. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Insider transactions (Form 4 / 3 / 5)
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Jun 18, 2026 | 8-K | Item 5.07; Financial Statements and Exhibits | ↗ |
| May 20, 2026 | 8-K | Material Direct Financial Obligation; Financial Statements and Exhibits | ↗ |
| May 5, 2026 | 10-Q | 10-Q | ↗ |
| May 5, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Apr 30, 2026 | ARS | ARS | ↗ |
| Apr 30, 2026 | DEFA14A | DEFA14A | ↗ |
| Apr 30, 2026 | DEF 14A | FORM DEF 14A | ↗ |
| Apr 30, 2026 | SCHEDULE 13G | ↗ | |
| Apr 29, 2026 | SCHEDULE 13G | ↗ | |
| Apr 22, 2026 | 8-K | Results of Operations (earnings) | ↗ |
| Apr 7, 2026 | 8-K | Entry into a Material Agreement; Completion of Acquisition/Disposition; Financial Statements and Exhibits | ↗ |
| Mar 27, 2026 | SCHEDULE 13G/A | ↗ | |
| Mar 18, 2026 | 4 | FORM 4 | ↗ |
| Mar 17, 2026 | 144 | ↗ | |
| Mar 16, 2026 | 144 | ↗ | |
| Mar 16, 2026 | 4 | FORM 4 | ↗ |
| Mar 16, 2026 | 4 | FORM 4 | ↗ |
| Mar 13, 2026 | 144 | ↗ | |
| Mar 12, 2026 | 144 | ↗ | |
| Mar 10, 2026 | 144 | ↗ | |
| Mar 10, 2026 | 4 | FORM 4 | ↗ |
| Mar 10, 2026 | 4 | FORM 4 | ↗ |
| Mar 10, 2026 | 4 | FORM 4 | ↗ |
| Mar 10, 2026 | 4 | FORM 4 | ↗ |
| Mar 10, 2026 | 3 | FORM 3 | ↗ |
| Mar 9, 2026 | 144 | ↗ | |
| Mar 9, 2026 | 144 | ↗ | |
| Mar 9, 2026 | 4 | FORM 4 | ↗ |
| Mar 6, 2026 | 144 | ↗ | |
| Mar 5, 2026 | 144 | ↗ | |
| Mar 3, 2026 | 4 | FORM 4 | ↗ |
| Mar 3, 2026 | 4 | FORM 4 | ↗ |
| Mar 3, 2026 | 4 | FORM 4 | ↗ |
| Mar 2, 2026 | 10-K | 10-K | ↗ |
| Feb 26, 2026 | 4 | FORM 4 | ↗ |
| Feb 26, 2026 | 4 | FORM 4 | ↗ |
| Feb 26, 2026 | 4 | FORM 4 | ↗ |
| Feb 26, 2026 | 4 | FORM 4 | ↗ |
| Feb 25, 2026 | 4 | FORM 4 | ↗ |
| Feb 25, 2026 | 4 | FORM 4 | ↗ |